| Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet 394 (10193), 121-130, 2019 | 2556 | 2019 |
| Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial SJ Robins, D Collins, JT Wittes, V Papademetriou, PC Deedwania, ... Jama 285 (12), 1585-1591, 2001 | 1081 | 2001 |
| Interchange of apolipoproteins between chylomicrons and high density lipoproteins during alimentary lipemia in man RJ Havel, JP Kane, ML Kashyap The Journal of clinical investigation 52 (1), 32-38, 1973 | 677 | 1973 |
| Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet 394 (10193), 131-138, 2019 | 593 | 2019 |
| Mechanism of action of niacin VS Kamanna, ML Kashyap The American journal of cardiology 101 (8), S20-S26, 2008 | 560 | 2008 |
| Distribution of lipids in 8,500 men with coronary artery disease HB Rubins, SJ Robins, D Collins, A Iranmanesh, TJ Wilt, D Mann, ... The American journal of cardiology 75 (17), 1196-1201, 1995 | 435 | 1995 |
| Relationship of apolipoproteins A-1 and B, and lipoprotein (a) to cardiovascular outcomes: the AIM-HIGH trial (Atherothrombosis Intervention in Metabolic Syndrome with Low HDL … JJ Albers, A Slee, KD O'Brien, JG Robinson, ML Kashyap, PO Kwiterovich, ... Journal of the American College of Cardiology 62 (17), 1575-1579, 2013 | 352 | 2013 |
| Long-term safety and efficacy of a once-daily niacin/lovastatin formulation for patients with dyslipidemia ML Kashyap, ME McGovern, K Berra, JR Guyton, PO Kwiterovich Jr, ... The American journal of cardiology 89 (6), 672-678, 2002 | 347 | 2002 |
| Equivalent efficacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemia RH Knopp, M Davidson, AC Goldberg, SD Kafonek, M Kashyap, ... Metabolism 47 (9), 1097-1104, 1998 | 287 | 1998 |
| Niacin noncompetitively inhibits DGAT2 but not DGAT1 activity in HepG2 cells1 SH Ganji, S Tavintharan, D Zhu, Y Xing, VS Kamanna, ML Kashyap Journal of lipid research 45 (10), 1835-1845, 2004 | 286 | 2004 |
| Niacin inhibits vascular oxidative stress, redox-sensitive genes, and monocyte adhesion to human aortic endothelial cells SH Ganji, S Qin, L Zhang, VS Kamanna, ML Kashyap Atherosclerosis 202 (1), 68-75, 2009 | 269 | 2009 |
| Niacin and cholesterol: role in cardiovascular disease SH Ganji, VS Kamanna, ML Kashyap The Journal of nutritional biochemistry 14 (6), 298-305, 2003 | 264 | 2003 |
| Niacin therapy in atherosclerosis CD Meyers, VS Kamanna, ML Kashyap Current opinion in lipidology 15 (6), 659-665, 2004 | 243 | 2004 |
| Mechanism of action of gemfibrozil on lipoprotein metabolism. K Saku, PS Gartside, BA Hynd, ML Kashyap The Journal of clinical investigation 75 (5), 1702-1712, 1985 | 242 | 1985 |
| Niacin decreases removal of high-density lipoprotein apolipoprotein AI but not cholesterol ester by Hep G2 cells: implication for reverse cholesterol transport FY Jin, VS Kamanna, ML Kashyap Arteriosclerosis, thrombosis, and vascular biology 17 (10), 2020-2028, 1997 | 229 | 1997 |
| Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol JR Guyton, MA Blazing, J Hagar, ML Kashyap, RH Knopp, JM McKenney, ... Archives of internal medicine 160 (8), 1177-1184, 2000 | 223 | 2000 |
| Relationship of lipoproteins to cardiovascular events: the AIM-HIGH trial (atherothrombosis intervention in metabolic syndrome with low HDL/high triglycerides and impact on … JR Guyton, AE Slee, T Anderson, JL Fleg, RB Goldberg, ML Kashyap, ... Journal of the American College of Cardiology 62 (17), 1580-1584, 2013 | 222 | 2013 |
| Comparative effects on lipid levels of combination therapy with a statin and extended-release niacin or ezetimibe versus a statin alone (the COMPELL study) JM McKenney, PH Jones, HE Bays, RH Knopp, ML Kashyap, GE Ruoff, ... Atherosclerosis 192 (2), 432-437, 2007 | 199 | 2007 |
| Comparison of once-daily, niacin extended-release/lovastatin with standard doses of atorvastatin and simvastatin (the ADvicor Versus Other Cholesterol-Modulating Agents Trial … HE Bays, CA Dujovne, ME McGovern, TE White, ML Kashyap, ... The American journal of cardiology 91 (6), 667-672, 2003 | 195 | 2003 |
| Mechanism of action of niacin on lipoprotein metabolism VS Kamanna, ML Kashyap Current atherosclerosis reports 2 (1), 36-46, 2000 | 195 | 2000 |